3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
4
Sarcoma
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Breast Neoplasms
2
Urologic Neoplasms
1
Thyroid Neoplasms
1
Soft Tissue Neoplasms
1
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Rhabdomyosarcoma
1
Recurrence
1
Pharyngeal Neoplasms
1
Patients With Advanced or Metastatic Solid Tumors
1
PRETEXT I Hepatoblastoma
1
Neurofibromatosis 2
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasms, Mesothelial
1
Mouth Neoplasms
1
Melanoma
1
Lymphangioleiomyomatosis
1
Lung Neoplasms
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Erdheim-Chester Disease
1
Endometrial Adenocarcinoma
1
Endocrine Gland Neoplasms
1
Interventions
pembrolizumab
18
Nivolumab
13
avelumab
10
Ipilimumab
7
Specimen Handling
6
cemiplimab
5
atezolizumab
5
Magnetic Resonance Spectroscopy
5
Biopsy
5
Radiotherapy
3
Cyclophosphamide
3
prednylidene
2
poly ICLC
2
lutetium Lu 177 dotatate
2
fludarabine phosphate
2
fludarabine
2
durvalumab
2
deltacortene
2
aldesleukin
2
Radiosurgery
2
Prednisone
2
Interleukin-2
2
Immunoglobulin G
2
Docetaxel
2
CTLA-4 Antigen
2
Bevacizumab
2
tocilizumab
1
talimogene laherparepvec
1
sargramostim
1
relatlimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Merkel Cell
×
temsirolimus
×
1 year
×
Clear all
No trials found.